Annual report pursuant to Section 13 and 15(d)

Stockholders' equity

v2.4.0.6
Stockholders' equity
12 Months Ended
Dec. 31, 2012
Equity [Abstract]  
Shareholders' equity
Stockholders’ equity
 
Common Stock
 
In 2012 and 2011 the Company raised additional funds through private placements of common stock to a limited number of accredited investors. In connection with the 2012 private placements the Company sold an aggregate of 850,000 shares of common stock at a purchase price of $0.80 per share, resulting in net cash proceeds of $680,000. In connection with the 2011 private placements the Company sold an aggregate of 4,716,919 shares of common stock at a purchase price ranging from $0.65 to $0.80 per share, resulting in net cash proceeds of $3,610,993.
 
On June 13, 2011, the Southern California Gas Company entered into an agreement with the Company to invest $500,000 in the Company’s Common Stock. The agreement included certain stockholder rights and a redemption right whereby the investor may redeem the shares for cash until the earlier of, the initiation of a public offering of the Company by filing a registration statement with the SEC, or five years. A letter of credit, secured by a Certificate of Deposit, for the amount of the investment has been put in place to satisfy the contingency of the redemption right. The Certificate of Deposit is classified as a short term investment in the accompanying balance sheet as of December 31, 2011. The Common Stock was classified outside of permanent equity because of the redemption right. The filing of our registration statement on Form S-1 on December 22, 2011, resulted in the expiration of the rights and preferences of the Southern California Gas Company; therefore we do not have any rights or preferences outstanding. As a result, we have reclassified this investment from Redeemable Common Stock, to permanent equity in the accompanying consolidated balance sheets.
 
The holders of Common Stock have the right to vote their interest on a per share basis. At December 31, 2012 and 2011 there were 54,447,854 and 53,993,882 shares of Common Stock outstanding, respectively.
 
Receivable from Shareholder
 
On June 3, 2010 the Company issued a promissory note to an investor in the amount of $345,000. The note was due in full on June 3, 2012 and bears interest at the Bank Prime Rate plus three percent. Accrued interest is paid on a quarterly basis. The note was secured by 1,150,000 shares of Tecogen Common Stock. The note was repaid with cash of $105,000 and return of 400,000 shares of common stock at a value of $0.60 per share, which were retired by the Company on December 7, 2012.
 

Stock-Based Compensation
 
In 2006, the Company adopted the 2006 Stock Option and Incentive Plan (the “Plan”), under which the board of directors may grant incentive or non-qualified stock options and stock grants to key employees, directors, advisors and consultants of the Company. The Plan was amended at various dates by the board to increase the reserved shares of common stock issuable under the Plan from 4,000,000 to 7,355,000 as of December 31, 2012 (the “Amended Plan”).
 
Stock options vest based upon the terms within the individual option grants, with an acceleration of the unvested portion of such options upon a change in control event, as defined in the Amended Plan. The options are not transferable except by will or domestic relations order. The option price per share under the Amended Plan cannot be less than the fair market value of the underlying shares on the date of the grant. The number of shares remaining available for future issuance under the Amended Plan as of December 31, 2012 and 2011 was 540,732 and 645,732, respectively.
 
In 2011, the company granted nonqualified options to purchase an aggregate of 1,921,000 shares of common stock at $0.65 per share and 125,000 shares of common stock at $0.70 per share. These options have a vesting schedule of four years and expire in ten years. The fair value of the options issued in 2011 was $508,586. The weighted-average grant date fair value of stock options granted during 2011 was $0.25 and 0.28 per option.
 
In 2012, the company granted nonqualified options to purchase an aggregate of 70,000 shares of common stock at $0.80 per share. These options have a vesting schedule of four years and expire in ten years. The fair value of the options issued in 2012 was $20,223. The weighted-average grant date fair value of stock options granted during 2012 was $0.29 per option. Stock option activity for the year ended December 31, 2012 and 2011 was as follows:
 
Common Stock Options
Number of
Options
 
Exercise
Price
Per
Share
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Life
 
Aggregate
Intrinsic
Value
Outstanding, December 31, 2010
2,480,000

 
$0.03-$0.50

 
$
0.32

 
3.30 years
 
$
793,500

Granted
2,046,000

 
0.65-0.70

 
0.65

 
 
 
 

Exercised

 

 

 
 
 
 

Canceled and forfeited

 

 

 
 
 
 

Repurchased
(50,000
)
 
0.25

 
0.25

 
 
 
 
Expired
(95,000
)
 
0.30-0.65

 
0.37

 
 
 
 

Outstanding, December 31, 2011
4,381,000

 
$0.03-$0.70

 
$
0.48

 
5.53 years
 
$
1,387,150

Exercisable, December 31, 2011
1,673,750

 
 

 
$
0.31

 
 
 
$
815,125

Vested and expected to vest, December 31, 2011
4,381,000

 
 

 
$
0.48

 
 
 
$
1,387,150

 
 
 
 
 
 
 
 
 
 
Outstanding, December 31, 2011
4,381,000

 
$0.03-$0.70

 
$
0.48

 
5.53 years
 
$
1,387,150

Granted
70,000

 
0.80

 
0.80

 
 
 
 

Exercised

 

 

 
 
 
 

Canceled and forfeited
(63,750
)
 
0.30-0.65

 
0.32

 
 
 
 

Expired
(1,250
)
 
0.65

 
0.65

 
 
 
 

Outstanding, December 31, 2012
4,386,000

 
$0.03-$0.80

 
$
0.49

 
4.66 years
 
$
1,356,400

Exercisable, December 31, 2012
2,650,250

 
 

 
$
0.39

 
 
 
$
1,096,225

Vested and expected to vest, December 31, 2012
4,386,000

 
 

 
$
0.49

 
 
 
$
1,356,400


 
The Company does not expect any forfeitures and the table above represents all stock options expected to vest. The Company uses the Black-Scholes option pricing model to determine the fair value of stock options granted. Use of a valuation model requires management to make certain assumptions with respect to selected model inputs. Expected volatility was calculated based on the average volatility of four comparable publicly traded companies. The average expected life was estimated using the simplified method to determine the expected life based on the vesting period and contractual terms, since it does not have the necessary historical exercise data to determine an expected life for stock options. The Company uses a single weighted-average expected life to value option awards and recognizes compensation on a straight-line basis over the requisite service period for each separately vesting portion of the awards. The risk-free interest rate is based on U.S. Treasury zero-coupon issues with a remaining term which approximates the expected life assumed at the date of grant.
 
In 2011, the Company purchased 50,000 options from a consultant at $0.25 per share. These options were due to expire on December 10, 2011 and would have allowed the holder to purchase shares of common stock of Tecogen for $0.25. The Company had no obligation to repurchase these shares. At December 10, 2011, the fair value of Tecogen’s common stock was $0.80. Since these options were purchased at below their estimated fair value, the price paid by Tecogen of $12,500 was charged to Stockholders’ equity.

The weighted average assumptions used in the Black-Scholes option pricing model for options granted in 2012 and 2011 are as follows:

 
2012
 
2011
Stock option awards:
 
 
 
Expected life
6.25 years
 
6.25 years
Risk-free interest rate
0.70%
 
2.46%
Expected volatility
35.9%-36.0%
 
33.8%-35.5%

 
In 2011, the Company made restricted stock grants to certain employees by permitting them to purchase an aggregate of 200,000 shares of common stock at a price of $0.001 per share. These shares vest over four years beginning six months after an initial public offering. The related compensation expense is recorded based on initial public offering date.
 
Restricted stock activity for the years ended December 31, 2012 and 2011 was as follows:
 
 
Number of
Restricted
Stock
 
Weighted
Average
Grant Date
Fair Value
Unvested, December 31, 2010
1,733,268

 
$
0.32

Granted
200,000

 
0.65

Vested

 

Forfeited

 

Unvested, December 31, 2011
1,933,268

 
$
0.36

 
 
 
 
Unvested, December 31, 2011
1,933,268

 
$
0.36

Granted

 

Vested

 

Forfeited
(336,988
)
 
0.34

Unvested, December 31, 2012
1,596,280

 
$
0.36


 
During the years ended December 31, 2012 and 2011, the Company recognized stock-based compensation of $136,184 and $396,724, respectively, related to the issuance of stock options and restricted stock. No tax benefit was recognized related to the stock-based compensation recorded during the years. At December 31, 2012 and 2011 there were 1,596,280 and 1,933,268 unvested shares of restricted stock outstanding, respectively. At December 31, 2012 and 2011 the total compensation cost related to unvested restricted stock awards and stock option awards not yet recognized is $183,230 and $537,540, respectively. This amount will be recognized over a weighted average period of 1.56 years.
 
Stock Based Compensation - Ilios
 
In 2009, Ilios adopted the 2009 Stock Incentive Plan (the “2009 Plan”) under which the board of directors may grant incentive or non-qualified stock options and stock grants to key employees, directors, advisors and consultants of the company. The maximum number of shares allowable for issuance under the Plan is 2,000,000 shares of common stock.
 
Stock options vest based upon the terms within the individual option grants, with an acceleration of the unvested portion of such options upon a change in control event, as defined in the Plan. The options are not transferable except by will or domestic relations order. The option price per share under the Plan cannot be less than the fair market value of the underlying shares on the date of the grant.
 
In 2011, Ilios granted nonqualified options to purchase an aggregate of 225,000 shares of common stock to certain employees at $0.50 per share. These options have a vesting schedule of four years and expire in ten years. The total fair value of the options issued in 2011 was $42,065. The weighted-average grant date fair value of stock options granted during 2011 was $0.19.

In 2012, Ilios granted nonqualified options to purchase 50,000 shares of common stock to a director at $0.50 per share. These options have a vesting schedule of four years and expire in ten years. The total fair value of the options issued in 2012 was $9,750. The weighted-average grant date fair value of stock options granted during 2012 was $0.20.

During the years ended December 31, 2012 and 2011 Ilios recognized stock-based compensation of $59,361 and $47,648, related to the issuance of stock options and restricted stock, respectively. No tax benefit was recognized related to the stock-based compensation recorded during the year. At December 31, 2012 and 2011 there were 510,000 and 560,000 unvested shares of restricted stock outstanding. At December 31, 2012 and 2011 the total compensation cost related to unvested restricted stock awards and stock option awards not yet recognized is $67,493 and $122,056, respectively. This amount will be recognized over the weighted average period of 1.67 years.
 
Stock option activity relating to Ilios for the year ended December 31, 2012 and 2011 was as follows:
 
Common Stock Options
Number of
Options
 
Exercise
Price
Per
Share
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Life
 
Aggregate
Intrinsic
Value
Outstanding, December 31, 2010
300,000

 
$
0.10

 
$
0.10

 
9.34 years
 
$
120,000

Granted
225,000

 
0.50

 
0.50

 
 
 
 

Exercised

 

 

 
 
 
 

Canceled and forfeited

 

 

 
 
 
 

Expired

 

 

 
 
 
 

Outstanding, December 31, 2011
525,000

 
$0.10-$0.50

 
$
0.27

 
8.23 years
 
$
120,000

Exercisable, December 31, 2011

 
 

 
$

 
 
 
$

Vested and expected to vest, December 31, 2011
525,000

 
 

 
$
0.27

 
 
 
$
120,000

 
 
 
 
 
 
 
 
 
 
Outstanding, December 31, 2011
525,000

 
$0.10-$0.50

 
$
0.27

 
8.23 years
 
$
120,000

Granted
50,000

 
0.50

 
0.50

 
 
 
 

Exercised

 

 

 
 
 
 

Canceled and forfeited

 

 

 
 
 
 

Expired

 

 

 
 
 
 

Outstanding, December 31, 2012
575,000

 
$0.10-$0.50

 
$
0.29

 
7.44 years
 
$
120,000

Exercisable, December 31, 2012

 
 

 
$
0.50

 
 
 
$

Vested and expected to vest, December 31, 2012
575,000

 
 

 
$
0.29

 
 
 
$
120,000


 
Ilios does not expect any forfeitures and the table above represents all stock options expected to vest. Ilios uses the Black-Scholes option pricing model to determine the fair value of stock options granted. Expected volatility was calculated based on the average volatility of comparable publicly traded companies, the expected life of the options was calculated using the simplified method, and the risk-free interest rate is based on U.S. Treasury zero-coupon issues with a remaining term which approximates the expected life assumed at the date of grant. The Company uses a single weighted-average expected life to value option awards and recognizes compensation on a straight-line basis over the requisite service period for each separately vesting portion of the awards.
 
For the Ilios awards, the weighted average assumptions used in the Black-Scholes option pricing model for options granted in 2012 and 2011 are as follows:

 
2012
 
2011
Stock option awards:
 
 
 
Expected life
6.25 years
 
6.25 years
Risk-free interest rate
2.03%
 
2.03%
Expected volatility
36.1%
 
34.2%

 
In 2011, Ilios made restricted stock grants to a certain Ilios employee by permitting him to purchase an aggregate of 200,000 shares of common stock at a price of $0.001 per share. These shares vest 25% one hundred eighty (180) days after an initial public offering of Ilios and 25% for 3 years thereafter. The related compensation expense is being recorded based on an anticipated initial public offering date.
 
Restricted stock activity for the Ilios awards, for the years ended December 31, 2012 and 2011 was as follows:
 
 
Number of
Restricted
Stock
 
Weighted
Average
Grant Date
Fair Value
Unvested, December 31, 2010
360,000

 
$
0.10

Granted
200,000

 
0.50

Vested

 

Forfeited

 

Unvested, December 31, 2011
560,000

 
$
0.24

 
 
 
 
Unvested, December 31, 2011
560,000

 
$
0.24

Granted

 

Vested

 

Forfeited
(50,000
)
 
0.10

Unvested, December 31, 2012
510,000

 
$
0.26